Suvretta Capital Management, LLC Pfizer Inc Transaction History

Suvretta Capital Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $1.31 Million - $1.71 Million	50,300 New	50,300 $1.45 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $47.3 Million - $53.1 Million	-1,279,800 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $46.7 Million - $51.3 Million	1,244,800 Added 3556.57%	1,279,800 $54.4 Million
Q4 2018 Feb 14, 2019	BUY	$38.47 - $43.86 $1.35 Million - $1.54 Million	35,000 New	35,000 $1.53 Million
Q2 2018 Aug 14, 2018	SELL	$32.98 - $35.16 $1.65 Million - $1.76 Million	-50,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $1.6 Million - $1.85 Million	50,000 New	50,000 $1.78 Million

3,219

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $165B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Suvretta Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Suvretta Capital Management, LLC with notifications on news.